Analyst consensus rating
Seaport Therapeutics Analyst Rating: Strong Buy
Direct answer
Seaport Therapeutics's consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $37.13.
Forecast evidence checked November 14, 2026.
Get free Seaport Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $19.98
- Average price target
- $37.13
- High price target
- $50.00
- Low price target
- $28.00
- Low target gap
- +40.1%
- Target upside
- +85.8%
- High target gap
- +150.3%
- Target range width
- 110.1%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Seaport Therapeutics?
Seaport Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $37.13.
How far are Seaport Therapeutics's low and high targets from the recorded price?
The low target implies +40.1%, while the high target implies +150.3%.
How many analysts are included in Seaport Therapeutics's consensus?
The verified consensus includes 8 analysts.
How is Seaport Therapeutics's target upside or downside calculated?
The average target of $37.13 is divided by the recorded price of $19.98, then one is subtracted to produce +85.8%. This does not guarantee a future return.
When was Seaport Therapeutics's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.